1942 (1942) Fair Value & Analysis

Technology · Market cap HK$115M

1 1942 1942 · HK

PriceHK$0.0780

Fair ValueHK$0.0250

Upside-68.0%

Quality28/100

Watch 1942 for free — get notified when fair value or trend changes. Watch for free

Evidence: Low Range HK$0.0250 – HK$0.0250

Fair value as of: Jul 2, 2026

From 3 valuation models · updated today

Share price −19.2% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.0696 – HK$0.6123 · the HK$0.0780 price screens above the HK$0.0250 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1942 (1942) currently trades at HK$0.0780, while our model-based Fair Value estimate is HK$0.0250 — implying the stock looks roughly 68.0% overvalued today. We read business quality at 28/100 (below-average quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 1942 generated revenue of HK$839M at a net margin of -10.6%. Revenue declined 48.9% year over year. It earns a return on equity of -12.6%. The balance sheet holds a net cash position of HK$26.0M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$839M

Revenue growth (YoY) -48.9%

Net margin -10.6%

Return on equity -12.6%

Free cash flow −HK$112M FY2026

Operating margin -19.3%

More key figures

EPS growth (YoY) -3.9%

Net cash HK$26.0M FY2023

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

1942 reported revenue of HK$839M in FY2026 versus HK$350M in FY2022, a compound +24.5%/yr. Reported net income was −HK$89.0M in FY2026.

Revenue +24.5%/yr

FY22 HK$350M

FY23 HK$467M

FY24 HK$1.4B

FY25 HK$1.3B

FY26 HK$839M

Net income

FY22 HK$15.3M

FY23 −HK$23.7M

FY24 −HK$75.6M

FY25 −HK$143M

FY26 −HK$89.0M

Is 1942 fairly valued? → Check now

Similar stocks

6 more Software - Infrastructure stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Microsoft Corporation MSF	€347.50	€211.04	-39%
MSFT MSFT	7,019 MXN	274.17 MXN	-96%
Oracle Corporation ORCL	$201.26	$43.29	-78%
Palantir Technologies Inc PTX	€114.20	€17.96	-84%
Palo Alto Networks, Inc 5AP	€231.80	€35.85	-85%
CrowdStrike Holdings CRWD	C$53.33	C$13.07	-75%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1942 (1942) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.0250 versus a price of HK$0.0780 — about −68% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1942?

Our model-based fair value for 1942 is HK$0.0250 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.0780.

What is the quality score of 1942?

1942 has a Quality Score of 28/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1942 (1942)?

1942 reported trailing-twelve-month revenue of about HK$839M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1942?

The net profit margin of 1942 is about -10.6%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.